Dennis Thiele
Directeur/Membre du Conseil chez Chaperone Therapeutics, Inc.
Profil
Dennis Thiele currently works at Chaperone Therapeutics, Inc., as Director and Sisu Pharma, Inc., as Director.
Postes actifs de Dennis Thiele
| Sociétés | Poste | Début |
|---|---|---|
Chaperone Therapeutics, Inc.
 Chaperone Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Chaperone Therapeutics, Inc. develops disease-modifying therapies for neurodegenerative and rare diseases caused by protein misfolding. Its therapeutic approach elevates the natural protein folding and stress protection mechanisms to prevent protein misfolding and the ensuing cell dysfunction and death. The company is headquartered in Chapel Hill, NC | Directeur/Membre du Conseil | - |
Sisu Pharma, Inc.
 Sisu Pharma, Inc. Pharmaceuticals: MajorHealth Technology Sisu Pharma, Inc. provides pharmaceutical services. The company is headquartered in Chapel Hill, NC. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Chaperone Therapeutics, Inc.
Chaperone Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Chaperone Therapeutics, Inc. develops disease-modifying therapies for neurodegenerative and rare diseases caused by protein misfolding. Its therapeutic approach elevates the natural protein folding and stress protection mechanisms to prevent protein misfolding and the ensuing cell dysfunction and death. The company is headquartered in Chapel Hill, NC | Commercial Services |
Sisu Pharma, Inc.
Sisu Pharma, Inc. Pharmaceuticals: MajorHealth Technology Sisu Pharma, Inc. provides pharmaceutical services. The company is headquartered in Chapel Hill, NC. | Health Technology |
